Indeed, Sakai et al.[28] reported that in heart failure post myocardial infarction long-term ETA blockade improved the survival rate, an analogy to the improvement obtained with angiotensin-converting enzyme (ACE) inhibition which resulted in the introduction of angiotensin-converting enzyme inhibitor (ACEi) as a gold standard therapy of heart failure [29]. This evidence concerns the gene ACE and heart failure.